Systemic immunosuppressive therapy and the occurrence of malignancy in patients with ocular inflammatory disease (Q73211674)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Systemic immunosuppressive therapy and the occurrence of malignancy in patients with ocular inflammatory disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

Alejandro Rodriguez-Garcia

2 November 2019

author

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L Lane

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Tamesis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

W Christen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Y A Akova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E Messmer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Pedroza-Seres

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

N Barney

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C S Foster

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 October 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1530-1535

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

Second malignant neoplasms associated with immunosuppressive medications

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Recent advances in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Treatment of nine cases of pemphigus vulgaris with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Azathioprine therapy of ?autoimmune? diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Cyclophosphamide-induced remissions in advanced polyarteritis nodosa

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

The incidence of malignant disease in patients receiving cytotoxic therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Review of United States data on neoplasms in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Long-lasting remission of Behcet's disease after chlorambucil therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Immunosuppressive therapy for external ocular inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Evaluation of prolonged cortisone therapy in rheumatiod arthritis: a four-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Effect of cortisone in the long-term treatment of rheumatoid arthritis: observation of thirty-five patients over a three-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Granulomatous sclerouveitis. Regression of ocular lesions with cyclophosphamide and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Neoplasms of the immune system in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Malignancy following treatment of rheumatoid arthritis with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Cancer and rheumatoid arthritis: epidemiologic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Epidemiology of cancer in rheumatoid arthritis: methodologic pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

The association of immune disease and malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Immune system in rheumatoid arthritis: possible implications in neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Malignancy in a series of 70 patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Increased Risk of Lymphoma in Sicca Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Malignant lymphomas of the thyroid.A clinical pathologic study of 35 patients including ultrastructural observations

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

Length of life and cause of death in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930835-4

7 January 2021

10.1016/S0161-6420(95)30835-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9097802%20AND%20SRC:MED&resulttype=core&format=json